Surgical treatments

Share this article →

With regard to the surgical treatment of vitiligo, Shane and colleagues from India write in the journal Dermatologic Surgery (2011; 37: 176-82) that the results of non-cultured pigment cell (melanocyte) transplantation (taken from the patient’s own normally pigmented skin) can be improved by suspending the melanocytes in the patients’ own serum: this could be an important innovation in the surgical management of patients with stable vitiligo.

Dr Mulekar and colleagues assessed the efficacy of the ReCell kit (Clinical Cell Culture, Cambridge, U.K.) and to compare it with conventional melanocyte-keratinocyte transplantation (MKT) for the treatment of vitiligo (Br J Dermatol 2008; 158: 45-9) and found of the five lesions treated with ReCell two lesions showed 100%, one 65% and one 40% repigmentation, and one lesion failed to repigment, whereas of the five lesions treated by conventional MKT three showed 100% and one 30% repigmentation and one failed to repigment (ReCell is not generally available in the UK).